11.09.2017

|

Press Releases

SHANGHAI, China (November 9, 2017) - On November 9, 2017, Perkins Coie LLP hosted a patent law seminar program at the Senmao Conference Center in Shanghai. The seminar addressed a variety of pressing intellectual property (IP) issues facing Chinese companies with business interests in the United States. Perkins Coie attorneys shared insights and strategies based on their experiences representing Chinese companies in connection with the companies’ U.S. intellectual property issues. Delegates from leading Chinese law firms, companies and multinational enterprises attended the seminar.

Perkins Coie Patent Litigation partner James Coughlan, firmwide co-chair of the firm’s International Trade Commission Section 337 Actions, and Patent Litigation partner Kevin Patariu presented updates on U.S. patent law, strategies for responding to allegations of IP infringement and approaches to obtaining valuable IP in a cost-effective manner. Patent Prosecution partner Aaron Wininger spoke about post-grant procedures at the USPTO and how these procedures can be used to attack patent validity or strengthen an issued patent.

“We believe that the insights we shared on these important topics in intellectual property law will help Chinese companies navigate a variety of challenges and opportunities in the United States,” said Kevin. “Recent U.S. patent law court decisions impact patent licensing strategy and supply chain structuring for Chinese companies. Cost-effective strategies for responding to allegations of patent, trademark, and copyright infringement, and for identifying the best intellectual property to obtain, will allow Chinese companies to mitigate risks and maximize opportunities.”

“Post-grant procedures such as post-grant review (PGR), covered business method (CBM) patent review, and inter partes review (IPR) continue to be important tools for Chinese companies to end patent litigations against them,” said Aaron. “Reissue, reexamination, and supplemental examination procedures at the USPTO are effective alternatives for Chinese companies to strengthen a patent in anticipation of patent litigation, licensing, or sale.”

Perkins Coie’s IP practice successfully prepares and prosecutes patent applications in anticipation of licensing opportunities and potential litigation. The group manages clients’ patent portfolios and provides strategies for strengthening and monetizing those portfolios. It also litigates patents in U.S. district courts across the United States and before the U.S. International Trade Commission. The group’s experience spans a range of industries, including computer science, electronics, semiconductors, telecommunications, life sciences and biotechnology, medical devices, aerospace and consumer products. Perkins Coie was just named the 2018 U.S. News – Best Lawyers® “Law Firm of the Year” in Patent Law, an honor it has received three times in six years, more than any other firm. The firm was also recently recognized as the leading law firm representing America’s largest companies in IP litigation by Corporate Counsel. Perkins Coie was named among the top ten firms representing patent owners before the USPTO PTAB by Lex Machina in its Patent Trial and Appeal Board (PTAB) 2017 Report, and Docket Navigator ranked Perkins Coie among the top 10 firms representing parties at the PTAB in 2016, the second year it received this recognition.

About Perkins Coie: Founded in 1912, Perkins Coie LLP has more than 1,000 lawyers in 19 offices across the United States and Asia. The firm provides a full array of corporate, commercial litigation and intellectual property legal services to a broad range of clients, from FORTUNE 50 corporations to emerging growth startups, as well as public and not-for-profit organizations.

Media Inquiries: Please email Terence Gordon, Media & Public Relations Manager.